All Articles

After spending many nights in pain, unable to breathe, Kayla Sanderson was told that the lump in her neck was “nothing” but a bad ear infection. Finally, she found out a tumor was blocking her airways. Read More ›

Carly Gerretsen, DNP, RN, FNP-C, RNFA, provides an overview of kidney cancer, explaining the various stages of a kidney cancer diagnosis, symptoms, treatment options, caregiver’s assistance, and stress management advice. Read More ›

In March 2021, the FDA approved Lorbrena (lorlatinib), a third-generation ALK inhibitor, for first-line treatment of patients with non–small-cell lung cancer and ALK mutation. Lorbrena was previously approved for the second- or third-line treatment for this patient population. Read More ›

In February 2021, the FDA approved Cosela (trilaciclib) as the first CDK4/6 inhibitor to reduce the risk of chemotherapy-induced myelosuppression in adults with extensive-stage small-cell lung cancer. Cosela can prevent damage to bone marrow cells by blocking the CDK4/6 enzyme. Read More ›

June is Pride Month, and the LGBTQ patient population with cancer faces a disproportionate burden because of a lack of data, a misunderstanding of this population by providers, and a lack of resources and education for patients. Read More ›

Let me share some good news with you: there are more treatment options today than ever before. Here’s what that means for you. Read More ›

Did you know that everyone has BRCA1 and BRCA2 genes? Let’s talk about these genes and what it means to have a mutation for you and your family. Read More ›

If you have HER2 positive breast cancer, you are not alone. Here’s what you should know about HER2 and targeted treatment options. Read More ›

Breastie noun (‘brest-ē’): A term of endearment among breast cancer survivors

Breasties Valarie Worthy, MSN, RN, and Ricki Fairley are making an impact in the lives of black breast cancer survivors. Here’s their inspiring story. Read More ›

We have all been affected by the coronavirus pandemic in some way. For cancer survivors, it can be difficult to process the time lost to COVID-19 after surviving the hardships of cancer treatment. Read More ›